GENOMICS IN THE FUTURE OF HEALTH – THE ROAD TO BETTER OUTCOMES?
Author(s)
Moderators: Bogi Eliasen, -, Associated Partner, Copenhagen Institute for Futures Studies, Copenhagen, Denmark Steven McAdam, -, Director of Health, DNV-GL, Oslo, Norway;
Panelists: Rajji Mehdwan, -, General Manager, Board Member, Roche, Amcham, Oslo, Norway; Terry Vrijenhoek, PhD, Program Manager, Center for Genome Diagnostics, University Medical Center Utrecht, Utrecht, Netherlands; Lars-Åke Levin, PhD, Professor, Division of Health Care Analysis, Linköping University, Linköping, Sweden; Kjetil Tasken, -, Director, Professor of Medicine, Institute for Cancer Research, Oslo University Hospital, University of Oslo, Oslo, Norway
Presentation Documents
The accelerating development in digital possibilities opens for better understanding of our biology where the progress in the field of genomics (and multiomics) has opened for new insight and understanding of health and disease. Personalized health is built on genomics and is seen as a necessary change for future health systems. At the same time, a host of questions need to be addressed to ensure that the new knowledge and tools bring about better outcomes. This session will bring together the two worlds of HEOR and clinical genomics to explore how implementation of these transformational technologies can be better guided by evidence. The current achievements of clinical genomics and approaches to assessing the costs and benefits of these emerging technologies will be reviewed followed by discussion on how health economics and outcomes research can be better used to influence how genomics is rolled out in the clinic.
Conference/Value in Health Info
2019-11, ISPOR Europe 2019, Copenhagen, Denmark
Code
SP2